IRF5 gene related symptoms and diseases

All the information presented here about the IRF5 gene and its related diseases, symptoms, and test panels has been aggregated from the following public sources: NCBIGENE,OMIM,ORPHANET,HGNC, Mendelian Rare Disease Search Engine.

Top 5 symptoms and clinical features associated to IRF5 gene

Symptoms // Phenotype % Cases
Autoimmunity Common - Between 50% and 80% cases
Abnormality of the skin Uncommon - Between 30% and 50% cases
Dysphagia Uncommon - Between 30% and 50% cases
Narrow foramen obturatorium Uncommon - Between 30% and 50% cases
Xerostomia Uncommon - Between 30% and 50% cases

Other less frequent symptoms and clinical features

Patients with IRF5 gene alterations may also develop some of the following symptoms and phenotypes:
  • Not very common - Between 30% and 50% cases

  • Antinuclear antibody positivity
  • Malabsorption
  • Weight loss
  • Diarrhea
  • Fatigue
  • Hypertension
  • Gastroesophageal reflux
  • Raynaud phenomenon

And 107 more phenotypes, you can get all of them using our tools for rare diseases.

Rare diseases associated to IRF5 gene

Here you will find a list of rare diseases related to the IRF5. You can also use our tool to get a more accurate diagnosis based on your current symptoms.


INFLAMMATORY BOWEL DISEASE 14; IBD14

LIMITED CUTANEOUS SYSTEMIC SCLEROSIS

Alternate names

LIMITED CUTANEOUS SYSTEMIC SCLEROSIS Is also known as limited cutaneous systemic scleroderma

Description

Limited cutaneous systemic sclerosis (lcSSc) is a subtype of systemic sclerosis (SSc; see this term) characterized by the association of Raynaud's phenomenon with skin fibrosis limited to the hands, face, feet and forearms.

Most common symptoms of LIMITED CUTANEOUS SYSTEMIC SCLEROSIS

  • Dysphagia
  • Gastroesophageal reflux
  • Autoimmunity
  • Nausea and vomiting
  • Abnormality of skin pigmentation


More info about LIMITED CUTANEOUS SYSTEMIC SCLEROSIS

SOURCES: ORPHANET

PRIMARY BILIARY CHOLANGITIS

Alternate names

PRIMARY BILIARY CHOLANGITIS Is also known as pbc, hanot syndrome, primary biliary cirrhosis

Description

Primary biliary cholangitis (PBC) is a chronic and slowly progressive cholestatic liver disease of autoimmune etiology characterized by injury of the intrahepatic bile ducts that may eventually lead to liver failure.

Most common symptoms of PRIMARY BILIARY CHOLANGITIS

  • Hypertension
  • Fatigue
  • Diarrhea
  • Encephalopathy
  • Osteoporosis


More info about PRIMARY BILIARY CHOLANGITIS

SOURCES: ORPHANET OMIM

DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

Alternate names

DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS Is also known as progressive cutaneous systemic scleroderma, diffuse cutaneous systemic scleroderma, progressive cutaneous systemic sclerosis

Description

Diffuse cutaneous systemic sclerosis (dcSSc) is a subtype of Systemic Sclerosis (SSc; see this term) characterized by truncal and acral skin fibrosis with an early and significant incidence of diffuse involvement (interstitial lung disease, oliguric renal failure, diffuse gastrointestinal disease, and myocardial involvement).

Most common symptoms of DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

  • Muscle weakness
  • Pain
  • Flexion contracture
  • Hypertension
  • Dysphagia


More info about DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

SOURCES: ORPHANET

SYSTEMIC LUPUS ERYTHEMATOSUS

Alternate names

SYSTEMIC LUPUS ERYTHEMATOSUS Is also known as disseminated lupus erythematosus, sle

Description

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by production of autoantibodies against nuclear, cytoplasmic, and cell surface molecules that transcend organ-specific boundaries. Tissue deposition of antibodies or immune complexes induces inflammation and subsequent injury of multiple organs and finally results in clinical manifestations of SLE, including glomerulonephritis, dermatitis, thrombosis, vasculitis, seizures, and arthritis. Evidence strongly suggests the involvement of genetic components in SLE susceptibility (summary by Oishi et al., 2008). Genetic Heterogeneity of Systemic Lupus ErythematosusAn autosomal recessive form of systemic lupus erythematosus (SLEB16 ) is caused by mutation in the DNASE1L3 gene (OMIM ) on chromosome 3p14.3.See MAPPING and MOLECULAR GENETICS sections for a discussion of genetic heterogeneity of susceptibility to SLE.

Most common symptoms of SYSTEMIC LUPUS ERYTHEMATOSUS

  • Seizures
  • Short stature
  • Cognitive impairment
  • Anemia
  • Fatigue


More info about SYSTEMIC LUPUS ERYTHEMATOSUS

SOURCES: OMIM ORPHANET

SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10


Potential gene panels for IRF5 gene

IRF5 Panel

United States.

By Fulgent Genetics Fulgent Genetics

This panel specifically test the IRF5 gene.

More info about this panel
United States.

Tempus xO assay Panel

United States.

By Tempus Labs, Inc. Tempus xO assay that also includes the following genes: BCL6 RHEB RIPK1 RIPK2 RIPK3 RIT1 BCL7A BCL9 BCR ROBO2

More info about this panel
United States.

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MT-ND6 ADA2 RMND1 TUBB2A ACP2 STAT2 HNRNPA2B1